Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic replacement therapy and glycaemic control in diabetes
ISRCTN14889127Phase 4Completed
- Sponsor
- Portsmouth Hospitals University NHS Trust
- Start
- Jun 2017
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
01
Overview
Phase 4, open-label trial of pancreatin in exocrine pancreatic insufficiency (EPI), sponsored by Portsmouth Hospitals University NHS Trust. Primary endpoint: Mean glucose interquartile range. Started Jun 2017; status: completed.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on ISRCTN14889127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14889127.